These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 14724815)
1. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Huang JQ; Zheng GF; Sumanac K; Irvine EJ; Hunt RH Gastroenterology; 2003 Dec; 125(6):1636-44. PubMed ID: 14724815 [TBL] [Abstract][Full Text] [Related]
2. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104 [TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study. Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185 [TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860 [TBL] [Abstract][Full Text] [Related]
5. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Parsonnet J; Friedman GD; Orentreich N; Vogelman H Gut; 1997 Mar; 40(3):297-301. PubMed ID: 9135515 [TBL] [Abstract][Full Text] [Related]
6. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193 [TBL] [Abstract][Full Text] [Related]
7. The evolving epidemiology of Helicobacter pylori infection and gastric cancer. Huang JQ; Hunt RH Can J Gastroenterol; 2003 Jun; 17 Suppl B():18B-20B. PubMed ID: 12845346 [TBL] [Abstract][Full Text] [Related]
8. Relationship between Helicobacter pylori CagA status and colorectal cancer. Shmuely H; Passaro D; Figer A; Niv Y; Pitlik S; Samra Z; Koren R; Yahav J Am J Gastroenterol; 2001 Dec; 96(12):3406-10. PubMed ID: 11774957 [TBL] [Abstract][Full Text] [Related]
9. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S; Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer. López-Carrillo L; Torres-López J; Galván-Portillo M; Muñoz L; López-Cervantes M Eur J Cancer; 2004 Jul; 40(11):1752-9. PubMed ID: 15251166 [TBL] [Abstract][Full Text] [Related]
13. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Chow WH; Blaser MJ; Blot WJ; Gammon MD; Vaughan TL; Risch HA; Perez-Perez GI; Schoenberg JB; Stanford JL; Rotterdam H; West AB; Fraumeni JF Cancer Res; 1998 Feb; 58(4):588-90. PubMed ID: 9485003 [TBL] [Abstract][Full Text] [Related]
14. [Helicobacter pylori CagA(+) infection in gastric cancer patients]. Ławniczak M; Starzyńska T Pol Merkur Lekarski; 2002 Sep; 13(75):216-20. PubMed ID: 12474574 [TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192 [TBL] [Abstract][Full Text] [Related]
16. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521 [TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori and gastric lymphoma: high seroprevalence of CagA in diffuse large B-cell lymphoma but not in low-grade lymphoma of mucosa-associated lymphoid tissue type. Delchier JC; Lamarque D; Levy M; Tkoub EM; Copie-Bergman C; Deforges L; Chaumette MT; Haioun C Am J Gastroenterol; 2001 Aug; 96(8):2324-8. PubMed ID: 11513169 [TBL] [Abstract][Full Text] [Related]
18. Association of gastric cancer, HLA-DQA1, and infection with Helicobacter pylori CagA+ and VacA+ in a Mexican population. Garza-González E; Bosques-Padilla FJ; Pérez-Pérez GI; Flores-Gutiérrez JP; Tijerina-Menchaca R J Gastroenterol; 2004 Dec; 39(12):1138-42. PubMed ID: 15622476 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Park JY; Forman D; Waskito LA; Yamaoka Y; Crabtree JE Toxins (Basel); 2018 Apr; 10(4):. PubMed ID: 29671784 [TBL] [Abstract][Full Text] [Related]
20. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status. Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]